-
A recent controversial move by a federal health agency to shut down a highly successful infection prevention program because it appeared to be involved in human research rather than quality improvement has ominous implications for traditional infection control activities, a leading epidemiologist tells Hospital Infection Control.
-
-
The Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality has created a "bladder bundle" of measures to prevent urinary tract infections. Some of the key recommendations for implementation of the bundle are summarized as follows:
-
Merck & Co. has initiated a voluntary recall in the United States for 10 lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and two lots of COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine].
-
Recall of a dozen lots of two Haemophilus influenzae type b (Hib) vaccines and suspension of production by a major manufacturer will result in a national shortage that could put children at risk and will certainly trouble physicians and parents in the short run, Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention, warns.
-
Though they are the most common infectious complication in hospitals, urinary tract infections (UTIs) get no respect.
-
Every day it seems there is another process change that caregivers are asked to make. These changes may come as the result of an improvement project or root cause analysis or may be needed to meet accreditation standards.
-
If a physician at your hospital observed that a colleague's substance abuse was putting patients in danger, would you expect that this information would be reported?
-
-
If Consumer Union, the nonprofit publisher of Consumer Reports has its way, all hospitals will soon begin publishing their hand-washing compliance rates information that for most organizations, would not be flattering.
